Stockreport

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

ENDRA Life Sciences Inc.  (NDRA) 
PDF Company accelerated enrollment in global multisite pilot study and significantly reduced operating expenses while refocusing resources to clinical and regulatory deliver [Read more]